Barclays’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | – | – | 4338 |
|
|
2025
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4371 |
|
|
2024
Q2 | – | Sell |
-2,706
| Closed | -$47K | – | 4173 |
|
|
2024
Q1 | $47K | Sell |
2,706
-2,608
| -49% | -$45.3K | ﹤0.01% | 3826 |
|
|
2023
Q4 | $69K | Buy |
5,314
+4,645
| +694% | +$60.3K | ﹤0.01% | 3789 |
|
|
2023
Q3 | $25K | Sell |
669
-745
| -53% | -$27.8K | ﹤0.01% | 3845 |
|
|
2023
Q2 | $56K | Sell |
1,414
-14,609
| -91% | -$579K | ﹤0.01% | 3621 |
|
|
2023
Q1 | $1.16M | Buy |
16,023
+4,526
| +39% | +$328K | ﹤0.01% | 2030 |
|
|
2022
Q4 | $942K | Sell |
11,497
-2,328
| -17% | -$191K | ﹤0.01% | 2181 |
|
|
2022
Q3 | $1.31M | Buy |
13,825
+12,961
| +1,500% | +$1.22M | ﹤0.01% | 1935 |
|
|
2022
Q2 | $168K | Sell |
864
-2,102
| -71% | -$409K | ﹤0.01% | 3234 |
|
|
2022
Q1 | $688K | Sell |
2,966
-6,362
| -68% | -$1.48M | ﹤0.01% | 2577 |
|
|
2021
Q4 | $3.68M | Sell |
9,328
-2,799
| -23% | -$1.1M | ﹤0.01% | 1432 |
|
|
2021
Q3 | $5.43M | Sell |
12,127
-188
| -2% | -$84.1K | ﹤0.01% | 1208 |
|
|
2021
Q2 | $4.79M | Buy |
12,315
+5,050
| +70% | +$1.96M | ﹤0.01% | 1229 |
|
|
2021
Q1 | $2.61M | Buy |
7,265
+4,482
| +161% | +$1.61M | ﹤0.01% | 1674 |
|
|
2020
Q4 | $1.37M | Sell |
2,783
-412
| -13% | -$202K | ﹤0.01% | 1809 |
|
|
2020
Q3 | $1.04M | Sell |
3,195
-1,055
| -25% | -$342K | ﹤0.01% | 1902 |
|
|
2020
Q2 | $1.55M | Buy |
4,250
+1,033
| +32% | +$376K | ﹤0.01% | 1643 |
|
|
2020
Q1 | $683K | Buy |
3,217
+582
| +22% | +$124K | ﹤0.01% | 1963 |
|
|
2019
Q4 | $1.09M | Buy |
2,635
+1,144
| +77% | +$471K | ﹤0.01% | 2244 |
|
|
2019
Q3 | $526K | Sell |
1,491
-1,976
| -57% | -$697K | ﹤0.01% | 2597 |
|
|
2019
Q2 | $1.74M | Buy |
3,467
+2,896
| +507% | +$1.46M | ﹤0.01% | 1924 |
|
|
2019
Q1 | $567K | Sell |
571
-1,082
| -65% | -$1.07M | ﹤0.01% | 2535 |
|
|
2018
Q4 | $1.44M | Buy |
1,653
+1,001
| +154% | +$870K | ﹤0.01% | 1573 |
|
|
2018
Q3 | $674K | Buy |
652
+533
| +448% | +$551K | ﹤0.01% | 2491 |
|
|
2018
Q2 | $110K | Sell |
119
-225
| -65% | -$208K | ﹤0.01% | 3028 |
|
|
2018
Q1 | $335K | Sell |
344
-3
| -0.9% | -$2.92K | ﹤0.01% | 2545 |
|
|
2017
Q4 | $158K | Sell |
347
-290
| -46% | -$132K | ﹤0.01% | 2784 |
|
|
2017
Q3 | $264K | Sell |
637
-35
| -5% | -$14.5K | ﹤0.01% | 2250 |
|
|
2017
Q2 | $235K | Buy |
672
+305
| +83% | +$107K | ﹤0.01% | 2357 |
|
|
2017
Q1 | $189K | Buy |
367
+20
| +6% | +$10.3K | ﹤0.01% | 2540 |
|
|
2016
Q4 | $121K | Buy |
347
+332
| +2,213% | +$116K | ﹤0.01% | 2527 |
|
|
2016
Q3 | $8K | Sell |
15
-177
| -92% | -$94.4K | ﹤0.01% | 3306 |
|
|
2016
Q2 | $108K | Buy |
192
+184
| +2,300% | +$104K | ﹤0.01% | 2314 |
|
|
2016
Q1 | $4K | Sell |
8
-20
| -71% | -$10K | ﹤0.01% | 3080 |
|
|
2015
Q4 | $18K | Buy |
28
+20
| +250% | +$12.9K | ﹤0.01% | 2714 |
|
|
2015
Q3 | $6K | Sell |
8
-3
| -27% | -$2.25K | ﹤0.01% | 3217 |
|
|
2015
Q2 | $14K | Buy |
11
+3
| +38% | +$3.82K | ﹤0.01% | 3124 |
|
|
2015
Q1 | $8K | Sell |
8
-11
| -58% | -$11K | ﹤0.01% | 3471 |
|
|
2014
Q4 | $12K | Buy |
+19
| New | +$12K | ﹤0.01% | 3649 |
|